Overview

EDP1867 Phase 1a/1b Study in Healthy Participants and Participants With Moderate Atopic Dermatitis and, Optionally, Moderate Psoriasis, and/or Mild Asthma

Status:
Recruiting
Trial end date:
2021-11-15
Target enrollment:
Participant gender:
Summary
This Phase 1 study will investigate the safety and tolerability of EDP1867 in healthy volunteers, participants with atopic dermatitis, and, optionally, in participants with psoriasis and/or asthma.
Phase:
Phase 1
Details
Lead Sponsor:
Evelo Biosciences, Inc.